Literature DB >> 24908070

Sophono Alpha System and subtotal petrosectomy with external auditory canal blind sac closure.

Giuseppe Magliulo1, Rosaria Turchetta, Giannicola Iannella, Riccardo Valperga di Masino, Riccardo Valpega di Masino, Marco de Vincentiis.   

Abstract

Recently, a new acoustic device, the so-called Sophono Alpha System, has been introduced into clinical practice. The aim of this study was to assess Sophono Alpha System hearing aids in ten patients suffering from recurrent chronic middle ear disease who underwent subtotal petrosectomy. Presence of mixed hearing loss with bone conduction thresholds better than or equal to 45 dB was present in each patient. Audiometric tests were performed before and after Sophono implantation and using a conventional bone conduction hearing aid (hearing glasses). Speech audiometry data (speech recognition threshold and word recognition score) were also collected. Speech recognition threshold in dB and percentage of word recognition score at 65 dB were subsequently calculated. After implantation and activation of the Sophono Alpha System, audiological data showed an average air conduction value of 42.1 dB. By comparing this data with the values of air conduction following subtotal petrosectomy, an average acoustic improvement of 29.7 dB could be calculated. The hearing results showed significantly better outcomes of Sophono Alpha System vs. conventional bone conduction aid. Indications to MRI use in patients undergoing Sophono Alpha System implantation are also provided.

Entities:  

Mesh:

Year:  2014        PMID: 24908070     DOI: 10.1007/s00405-014-3123-2

Source DB:  PubMed          Journal:  Eur Arch Otorhinolaryngol        ISSN: 0937-4477            Impact factor:   2.503


  31 in total

1.  Benefit and quality of life in older bone-anchored hearing aid users.

Authors:  Maarten J F de Wolf; My-Linh C Shival; Myrthe K S Hol; Emmanuel A M Mylanus; Cor W R J Cremers; Ad F M Snik
Journal:  Otol Neurotol       Date:  2010-07       Impact factor: 2.311

2.  BAHA implant: implantation technique and complications.

Authors:  N Fontaine; P Hemar; P Schultz; A Charpiot; C Debry
Journal:  Eur Ann Otorhinolaryngol Head Neck Dis       Date:  2013-07-05       Impact factor: 2.080

3.  MRI artefacts after Bonebridge implantation.

Authors:  C Steinmetz; I Mader; S Arndt; A Aschendorff; R Laszig; F Hassepass
Journal:  Eur Arch Otorhinolaryngol       Date:  2014-03-18       Impact factor: 2.503

4.  Mastoid and epitympanic obliteration in canal wall up mastoidectomy for prevention of retraction pocket.

Authors:  Won Sang Lee; Jae Young Choi; Mee Hyun Song; Eun Jin Son; Sang Ho Jung; Sung Huhn Kim
Journal:  Otol Neurotol       Date:  2005-11       Impact factor: 2.311

5.  Indications and outcome of subtotal petrosectomy for active middle ear implants.

Authors:  Nicolas Verhaert; Hamidreza Mojallal; Burkard Schwab
Journal:  Eur Arch Otorhinolaryngol       Date:  2012-07-25       Impact factor: 2.503

Review 6.  An overview of different systems: the bone-anchored hearing aid.

Authors:  Catharina A J Dun; Hubert T Faber; Maarten J F de Wolf; Cor W R J Cremers; Myrthe K S Hol
Journal:  Adv Otorhinolaryngol       Date:  2011-03-08

7.  Bone-anchored hearing aids: results of the first eight years of a programme in a district general hospital, assessed by the Glasgow benefit inventory.

Authors:  D Gillett; J W Fairley; T S Chandrashaker; A Bean; J Gonzalez
Journal:  J Laryngol Otol       Date:  2006-05-04       Impact factor: 1.469

8.  Retrosigmoid implantation of an active bone conduction stimulator in a patient with chronic otitis media.

Authors:  Luis Lassaletta; Isabel Sanchez-Cuadrado; Elena Muñoz; Javier Gavilan
Journal:  Auris Nasus Larynx       Date:  2013-05-28       Impact factor: 1.863

9.  The Bonebridge: preclinical evaluation of a new transcutaneously-activated bone anchored hearing device.

Authors:  A M Huber; J H Sim; Y Z Xie; M Chatzimichalis; O Ullrich; C Röösli
Journal:  Hear Res       Date:  2013-03-01       Impact factor: 3.208

10.  Hearing aid tolerance after revision and obliteration of canal wall down mastoidectomy cavities.

Authors:  Michael B Gluth; Adva B Friedman; Samuel R Atcherson; John L Dornhoffer
Journal:  Otol Neurotol       Date:  2013-06       Impact factor: 2.311

View more
  6 in total

1.  Massive Cerebrospinal Fluid Leak of the Temporal Bone.

Authors:  Giannicola Iannella; Alessandra Manno; Emanuela Pasqualitto; Andrea Ciofalo; Diletta Angeletti; Benedetta Pasquariello; Giuseppe Magliulo
Journal:  Case Rep Otolaryngol       Date:  2016-08-11

2.  Three-year experience with the Sophono in children with congenital conductive unilateral hearing loss: tolerability, audiometry, and sound localization compared to a bone-anchored hearing aid.

Authors:  Rik C Nelissen; Martijn J H Agterberg; Myrthe K S Hol; Ad F M Snik
Journal:  Eur Arch Otorhinolaryngol       Date:  2016-02-29       Impact factor: 2.503

3.  Three year experience with the cochlear BAHA attract implant: a systematic review of the literature.

Authors:  Panagiotis A Dimitriadis; Matthew R Farr; Ahmed Allam; Jaydip Ray
Journal:  BMC Ear Nose Throat Disord       Date:  2016-10-01

4.  Hearing and hearing rehabilitation after obliteration of troublesome mastoid cavities.

Authors:  Simon Geerse; Tim J M Bost; Samira Allagul; Maarten J F de Wolf; Fenna A Ebbens; Erik van Spronsen
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-05-22       Impact factor: 2.503

5.  Surgical and Audiologic Comparison Between Sophono and Bone-Anchored Hearing Aids Implantation.

Authors:  Joong-Wook Shin; Sung Huhn Kim; Jae Young Choi; Hong-Joon Park; Seung-Chul Lee; Jee-Sun Choi; Han Q Park; Ho-Ki Lee
Journal:  Clin Exp Otorhinolaryngol       Date:  2016-03-07       Impact factor: 3.372

6.  The Prediction of Speech Recognition in Noise With a Semi-Implantable Bone Conduction Hearing System by External Bone Conduction Stimulation With Headband: A Prospective Study.

Authors:  Friedrich Ihler; Jenny Blum; Max-Ulrich Berger; Bernhard G Weiss; Christian Welz; Martin Canis
Journal:  Trends Hear       Date:  2016-10-03       Impact factor: 3.293

  6 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.